phillyrin has been researched along with Orthomyxoviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Chen, Y; Cong, W; Fu, L; Leng, SX; Li, H; Pekosz, A; Powell, H; Wu, C; Zhu, G | 1 |
| Li, W; Liu, C; Liu, X; Liu, Z; Qi, D; Qi, J; Song, X; Sun, F; Wang, N; Wang, W; Wang, X; Zhang, D; Zhang, S; Zhu, J | 1 |
2 other study(ies) available for phillyrin and Orthomyxoviridae Infections
| Article | Year |
|---|---|
Antiviral effect and mechanism of Phillyrin and its reformulated FS21 against influenza.
Topics: Animals; Antiviral Agents; Dogs; Glucosides; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Madin Darby Canine Kidney Cells; Neuraminidase; Orthomyxoviridae Infections; Viral Replicase Complex Proteins | 2023 |
Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation.
Topics: Animals; Inflammasomes; Influenza A Virus, H1N1 Subtype; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Orthomyxoviridae Infections; Pneumonia, Viral | 2023 |